A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)

Authors:
  • HJHyun Ae Jung
    Hyun Ae Jung
  • MKMiso Kim
    Miso Kim
  • HKHae Su Kim
    Hae Su Kim
  • JKJoo-Hang Kim
    Joo-Hang Kim
  • YCYoon Hee Choi
    Yoon Hee Choi
  • JCJinhyun Cho
    Jinhyun Cho
  • JPJi Hyun Park
    Ji Hyun Park
  • KPKeon Uk Park
    Keon Uk Park
  • BKBo Mi Ku
    Bo Mi Ku
  • SPSehhoon Park
    Sehhoon Park
  • JSJong-Mu Sun
    Jong-Mu Sun
  • SLSe-Hoon Lee
    Se-Hoon Lee

Abstract
No abstract available
Funding Information
  • Ministry of Science, ICT and Future Planning (2021-0-02068)
  • Ministry of Health and Welfare (HA22C0012)
  • Pfizer

This publication has 22 references indexed in Scilit: